PubRank

Saskia J A M Santegoets

Author PubWeight™ 18.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol 2012 3.10
2 Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients. J Transl Med 2013 1.40
3 Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients. Clin Cancer Res 2008 1.24
4 CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur J Immunol 2008 1.15
5 Research resource: transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells. Mol Endocrinol 2010 1.15
6 Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. J Virol 2010 0.93
7 Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation. Oncoimmunology 2013 0.92
8 IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiation. PLoS One 2013 0.87
9 Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors. J Leukoc Biol 2009 0.86
10 Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells. J Immunother 2006 0.84
11 Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus. J Immunother 2010 0.83
12 Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival. Int J Cancer 2014 0.80
13 A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate system. Mol Pharm 2005 0.78
14 Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy. Oncoimmunology 2013 0.77
15 Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α. Clin Immunol 2011 0.76
16 An α-galactosylceramide nose job shapes up iNKT cells. Immunotherapy 2012 0.75
17 Gram-positive bacteria: a major microbial ‘turn-on’ for invariant NKT cells. Immunotherapy 2012 0.75
18 Bulldozing β-linked glycolipids for recognition by invariant NKT cells. Immunotherapy 2012 0.75
19 The Thirteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-13), October 2-4, 2013, Amsterdam, The Netherlands: the current standing of anti-tumor immunotherapeutic approaches. Cancer Immunol Immunother 2014 0.75